Dermata Therapeutics, Inc. (DRMA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
3525 Del Mar Heights Road
San Diego, CA 92130
United States of America (the)
Phone
858 800 2543
Website
Sector
Healthcare
Industry
Biotechnology
Employees
9
First IPO Date
August 13, 2021
| Name | Title | Pay | Year Born |
| Gerald T. Proehl | Founder, President, Chief Executive Officer & Chairman | 420,000 | 1959 |
| Maria Bedoya Toro Munera | Senior Vice President of Regulatory Affairs & Quality Assurance | 27,040 | 1951 |
| David F. Hale | Co-Founder & Lead Independent Director | 73,000 | 1949 |
| Kyri K. Van Hoose | Senior Vice President & Chief Financial Officer | 485,195 | 1978 |
| Christopher J. Nardo | Senior Vice President & Chief Development Officer | 513,765 | 1965 |
| Kyra Peckaitis | Vice President of Marketing | 0 | N/A |
| Sean Proehl | Associate General Counsel | 0 | N/A |
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.